OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanobodies asin vivo, non-invasive, imaging agents
Thibault J. Harmand, Ashraful Islam, Novalia Pishesha, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 3, pp. 685-701
Open Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Advances in PET imaging of cancer
Johannes Schwenck, Dominik Sonanini, Jonathan Cotton, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 474-490
Closed Access | Times Cited: 105

Development and Characterization of Nanobody-Derived CD47 Theranostic Pairs in Solid Tumors
You Zhang, Di Zhang, Shuxian An, et al.
Research (2023) Vol. 6, pp. 0077-0077
Open Access | Times Cited: 31

Molecular and functional insight into anti-EGFR nanobody: Theranostic implications for malignancies
Rajan K. Tripathy, Abhay H. Pande
Life Sciences (2024) Vol. 345, pp. 122593-122593
Closed Access | Times Cited: 9

CDH17 nanobodies facilitate rapid imaging of gastric cancer and efficient delivery of immunotoxin
Jingbo Ma, Xiaolong Xu, Chunjin Fu, et al.
Biomaterials Research (2022) Vol. 26, Iss. 1
Open Access | Times Cited: 30

Nanobody‐Engineered Biohybrid Bacteria Targeting Gastrointestinal Cancers Induce Robust STING‐Mediated Anti‐Tumor Immunity
Xiaolong Xu, Youbin Ding, Yafang Dong, et al.
Advanced Science (2024) Vol. 11, Iss. 31
Open Access | Times Cited: 6

30 years of nanobodies – an ongoing success story of small binders in biological research
Desiree I. Frecot, Theresa Froehlich, Ulrich Rothbauer
Journal of Cell Science (2023) Vol. 136, Iss. 21
Open Access | Times Cited: 14

An armed anti-immunoglobulin light chain nanobody protects mice against influenza A and B infections
Xin Liu, Thomas Balligand, Claire Carpenet, et al.
Science Immunology (2023) Vol. 8, Iss. 84
Open Access | Times Cited: 13

AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Niels Vandewalle, Hatice Satilmis, Emma Verheye, et al.
Theranostics (2024) Vol. 14, Iss. 7, pp. 2656-2674
Open Access | Times Cited: 5

Synthesis, preclinical evaluation and pilot clinical translation of [68Ga]Ga-PMD22, a novel nanobody PET probe targeting CLDN18.2 of gastrointestinal cancer
Rongxi Wang, Zhidong Bai, Wentao Zhong, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2024) Vol. 51, Iss. 12, pp. 3731-3743
Closed Access | Times Cited: 5

PET imaging of HIV-1 envelope protein gp120 using 18F-labeled nanobodies
Neysha Martínez‐Orengo, Swati Shah, Jianhao Lai, et al.
iScience (2025) Vol. 28, Iss. 2, pp. 111795-111795
Open Access

Molecular imaging of viral pathogenesis and opportunities for the future
Brianna Kelly, Jeanette E. Boudreau, Steven Beyea, et al.
npj Imaging (2025) Vol. 3, Iss. 1
Open Access

From antibodies to nanobodies: The next frontier in cancer theranostics for solid tumors
Sanjana Mehrotra, Navdeep Kaur, Sukhpreet Kaur, et al.
Advances in protein chemistry and structural biology (2025)
Closed Access

Indium-111-Labeled Single-Domain Antibody for In Vivo CXCR4 Imaging Using Single-Photon Emission Computed Tomography
M. SPAHN, Stephanie Mareike Anbuhl, Kaat Luyten, et al.
Bioconjugate Chemistry (2025)
Closed Access

Optimizing antibody PET imaging: a comparative preclinical analysis of nanobody and minibody-like PET tracers
Katty Zeven, Herlinde Dierick, Matthijs B. Sevenois, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2025)
Open Access

Chemoenzymatic Site-Specific Lysine Modification of Nanobodies and Subsequent Bioconjugation via Potassium Acyltrifluoroborate (KAT) Ligations
Jinling Wang, Kateryna A. Tolmachova, Jeffrey W. Bode
Journal of the American Chemical Society (2025)
Closed Access

Selective Targeting of Nanobody-Modified Gold Nanoparticles to Distinct Cell Types
Yoon Ho Lee, Himadri Medhi, Xin Liu, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 51, pp. 59258-59268
Closed Access | Times Cited: 10

Two birds with one stone: human SIRPα nanobodies for functional modulation and in vivo imaging of myeloid cells
Teresa R. Wagner, Simone Blaess, Inga B. Leske, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8

Nanobodies: COVID-19 and Future Perspectives
G Valenzuela, Zaray Miranda-Chacón, Constanza Salinas-Rebolledo, et al.
Frontiers in Drug Discovery (2022) Vol. 2
Open Access | Times Cited: 13

Activation of a G protein-coupled receptor through indirect antibody-mediated tethering of ligands
Ross W. Cheloha, Fabian A. Fischer, Thomas J. Gardella, et al.
RSC Chemical Biology (2021) Vol. 2, Iss. 6, pp. 1692-1700
Open Access | Times Cited: 16

Mono- and Bi-specific Nanobodies Targeting the CUB Domains of PCPE-1 Reduce the Proteolytic Processing of Fibrillar Procollagens
Priscillia Lagoutte, Jean‐Marie Bourhis, Natacha Mariano, et al.
Journal of Molecular Biology (2024) Vol. 436, Iss. 16, pp. 168667-168667
Open Access | Times Cited: 2

Combining poly-epitope MoonTags and labeled nanobodies for signal amplification in cell-specific PET imaging in vivo
Katharina S. Höffgen, Jennifer Dabel, Christian Paul Konken, et al.
Nuclear Medicine and Biology (2024) Vol. 136-137, pp. 108937-108937
Open Access | Times Cited: 2

Understanding immunity in a tissue‐centric context: Combining novel imaging methods and mathematics to extract new insights into function and dysfunction*
Ronald N. Germain, Andrea J. Radtke, Nishant Thakur, et al.
Immunological Reviews (2021) Vol. 306, Iss. 1, pp. 8-24
Closed Access | Times Cited: 15

Page 1 - Next Page

Scroll to top